Däbritz, J., Judd, L. M., Chalinor, H. V., Menheniott, T. R., & Giraud, A. S. (2016). Altered gp130 signalling ameliorates experimental colitis via myeloid cell-specific STAT3 activation and myeloid-derived suppressor cells. Sci Rep.

Däbritz, Jan, Louise M. Judd, Heather V. Chalinor, Trevelyan R. Menheniott, and Andrew S. Giraud. "Altered Gp130 Signalling Ameliorates Experimental Colitis Via Myeloid Cell-specific STAT3 Activation and Myeloid-derived Suppressor Cells." Sci Rep 2016.

Däbritz, Jan, et al. "Altered Gp130 Signalling Ameliorates Experimental Colitis Via Myeloid Cell-specific STAT3 Activation and Myeloid-derived Suppressor Cells." Sci Rep 2016.